Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00151411 · ClinicalTrials.gov registry record · Phase 2
Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)
A Phase 2 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 114
- Enrollment target
NCT00151411: Completed Phase 2 study, sponsored by Milton S. Hershey Medical Center.
NCT00151411 is a Phase 2 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 114 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00151411, a Phase 2 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the combination therapy of lifestyle intervention and use of Metformin together will improve ovulation induction and hyperandrogenemia in women with polycystic ovary syndrome, by gathering data from adult and adolescent females.
Interventions
- DRUG Placebo
- DRUG Metformin
- BEHAVIORAL Lifestyle Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
What the finished NCT00151411 record still lists
NCT00151411 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (14% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00151411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00151411 about?
NCT00151411 is a clinical study titled "Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)". The purpose of this study is to determine if the combination therapy of lifestyle intervention and use of Metformin together will improve ovulation induction and hyperandrogenemia in women with polycystic ovary syndrome, by gathering data from adult and adolescent females.
What is the current status of trial NCT00151411?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 114 participants. The study started on 2004-10. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00151411?
The interventions under investigation include: Placebo (DRUG), Metformin (DRUG), Lifestyle Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00151411?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00151411's enrollment target sits among peer trials
114 627th of 2000 higher than 1,370 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia